Interventional Therapy for High Risk Pulmonary Embolism:a Review of Ten Years
傅军,李选,韩金涛,王昌明,栾景源,李天润,翟国钧,冯琦琛,庄金满,赵军,董国祥
DOI: https://doi.org/10.3969/j.issn.1009-6604.2015.01.004
2015-01-01
Abstract:Objective To explore the safety and efficacy of interventional therapy for high-risk pulmonary embolism. Methods We retrospectively analyzed 94 cases of high-risk pulmonary embolism who received interventional therapy ( thrombectomy, rapid thrombolysis plus anticoagulation, or mechanical embolus removal) from December 2002 to September 2012.Vital signs, heart functions, and clinical outcomes were observed and compared. Results Among the 94 cases, the success rate of operation was 98.9%(1 patient died during the interventional procedure).Six patients died after operation.In the remaining 88 cases, loss of follow-up occurred in 16 cases and 72 cases were followed for an average of 23.5 months (13-130 months), the rate of follow-up being 81.8%(72/88) .The cardiac functions were classified as class Ⅰ in 68 cases, class Ⅱ in 3 cases, and class Ⅳ in 1 case. According to our criteria, there were 68 cases of complete remission (94.4%, 68/72), 3 cases of partial improvement (4.2%, 3/72), and 1 case of inefficacy (1.4%, 1/72). Conclusion Interventional treatment for high-risk pulmonary embolism is an effective procedure, which can quickly and efficiently improve the prognosis and the life quality.